Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner

Immunity

Volumn 48, Issue 3, 2018, Pages 570-583.e8

  O'Reilly, Lorraine A ^a,b   Putoczki, Tracy L ^a,b   Mielke, Lisa A ^a,b   Low, Jun T ^a,b   Lin, Ann ^a   Preaudet, Adele ^a   Herold, Marco J ^a,b   Yaprianto, Kelvin ^a,b,h   Tai, Lin ^a   Kueh, Andrew ^a,b   Pacini, Guido ^a   Ferrero, Richard L ^c   Gugasyan, Raffi ^d,e   Hu, Yifang ^a   Christie, Michael ^b   Wilcox, Stephen ^a,b   Grumont, Raelene ^e   Griffin, Michael D W ^b,f   O'Connor, Liam ^a,b   Smyth, Gordon K ^a,b   Ernst, Mathias ^g   Waring, Paul ^b   Gerondakis, Steve ^e   Strasser, Andreas ^a,b   more..

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d BURNET INSTITUTE   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g OLIVIA NEWTON JOHN CANCER RESEARCH INSTITUTE   (Australia)

^h UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT1 PROTEIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GASTRITIS; HEMATOPOIETIC CELL; HISTOPATHOLOGY; IMMUNE SYSTEM; JAK-STAT SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RNA SEQUENCE; STOMACH ADENOCARCINOMA; ANIMAL; BONE MARROW CELL; CELL TRANSFORMATION; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; STOMACH TUMOR;

ANIMALS; ANTIGEN PRESENTATION; BONE MARROW CELLS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; INFLAMMATION; MICE; MICE, KNOCKOUT; NF-KAPPA B; STAT1 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS;

EID: 85043771139     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2018.03.003     Document Type: Article

References (72)

1. Arisawa, T., Tahara, T., Shiroeda, H., Yamada, K., Nomura, T., Yamada, H., Hayashi, R., Matsunaga, K., Otsuka, T., Nakamura, M., Shimasaki, T., Toshikuni, N., Kawada, N., Shibata, T., Functional promoter polymorphisms of NFKB1 influence susceptibility to the diffuse type of gastric cancer. Oncol Rep. 30 (2013), 3013–3019.
2. Aubrey, B.J., Kelly, G.L., Kueh, A.J., Brennan, M.S., O'Connor, L., Milla, L., Wilcox, S., Tai, L., Strasser, A., Herold, M.J., An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo. Cell Rep. 10 (2015), 1422–1432.
3. Brahmer, J.R., Tykodi, S.S., Chow, L.Q., Hwu, W.J., Topalian, S.L., Hwu, P., Drake, C.G., Camacho, L.H., Kauh, J., Odunsi, K., et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366 (2012), 2455–2465.
4. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513 (2014), 202–209.
5. Cao, S., Zhang, X., Edwards, J.P., Mosser, D.M., NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J. Biol. Chem. 281 (2006), 26041–26050.
6. Carpenter, R.L., Lo, H.W., STAT3 Target Genes Relevant to Human Cancers. Cancers (Basel) 6 (2014), 897–925.
7. Chen, Y., Lu, R., Zheng, H., Xiao, R., Feng, J., Wang, H., Gao, X., Guo, L., The NFKB1 polymorphism (rs4648068) is associated with the cell proliferation and motility in gastric cancer. BMC Gastroenterol., 15, 2015, 21.
8. Cheng, C.S., Feldman, K.E., Lee, J., Verma, S., Huang, D.B., Huynh, K., Chang, M., Ponomarenko, J.V., Sun, S.C., Benedict, C.A., et al. The specificity of innate immune responses is enforced by repression of interferon response elements by NF-κB p50. Sci. Signal., 4, 2011, ra11.
9. Correa, P., Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52 (1992), 6735–6740.
10. de Valle, E., Grigoriadis, G., O'Reilly, L.A., Willis, S.N., Maxwell, M.J., Corcoran, L.M., Tsantikos, E., Cornish, J.K., Fairfax, K.A., Vasanthakumar, A., et al. NFκB1 is essential to prevent the development of multiorgan autoimmunity by limiting IL-6 production in follicular B cells. J. Exp. Med. 213 (2016), 621–641.
11. Dumitru, C.D., Ceci, J.D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J.H., Patriotis, C., Jenkins, N.A., Copeland, N.G., Kollias, G., Tsichlis, P.N., TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103 (2000), 1071–1083.
12. Elsharkawy, A.M., Oakley, F., Lin, F., Packham, G., Mann, D.A., Mann, J., The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. J. Hepatol. 53 (2010), 519–527.
13. Ferrero, R.L., Avé P., Radcliff, F.J., Labigne, A., Huerre, M.R., Outbred mice with long-term Helicobacter felis infection develop both gastric lymphoid tissue and glandular hyperplastic lesions. J. Pathol. 191 (2000), 333–340.
14. Fuchs, C.S., Doi, T., Jang, R.W.J., Muro, K., Satoh, T., Machado, M., et al. KEYNOTE-059 cohort 1: Efficacy and safety of pembrolizumab (pembro) monotherapy in patients with previously treated advanced gastric cancer. J. Clin. Oncol., 35, 2017 4003–4003.
15. Gkirtzimanaki, K., Gkouskou, K.K., Oleksiewicz, U., Nikolaidis, G., Vyrla, D., Liontos, M., Pelekanou, V., Kanellis, D.C., Evangelou, K., Stathopoulos, E.N., et al. TPL2 kinase is a suppressor of lung carcinogenesis. Proc. Natl. Acad. Sci. USA 110 (2013), E1470–E1479.
16. Glocker, E., Lange, C., Covacci, A., Bereswill, S., Kist, M., Pahl, H.L., Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation. Infect. Immun. 66 (1998), 2346–2348.
17. Grumont, R.J., Gerondakis, S., The subunit composition of NF-kappa B complexes changes during B-cell development. Cell Growth Differ. 5 (1994), 1321–1331.
18. Grumont, R.J., Richardson, I.B., Gaff, C., Gerondakis, S., Rel/NF-kB nuclear complexes that bind kB sites in the murine C-Rel promoter are required for constitutive C-Rel transcription in B-cells. Cell Growth Differ. 4 (1993), 731–743.
19. Hansen, S.K., Nerlov, C., Zabel, U., Verde, P., Johnsen, M., Baeuerle, P.A., Blasi, F., A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO J. 11 (1992), 205–213.
20. He, G., Karin, M., NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res. 21 (2011), 159–168.
21. Herold, M.J., van den Brandt, J., Seibler, J., Reichardt, H.M., Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc. Natl. Acad. Sci. USA 105 (2008), 18507–18512.
22. Hua, T., Qinsheng, W., Xuxia, W., Shuguang, Z., Ming, Q., Zhenxiong, L., Jingjie, W., Nuclear factor-kappa B1 is associated with gastric cancer in a Chinese population. Medicine., 93, 2014, e279.
23. Jenkins, B.J., Grail, D., Nheu, T., Najdovska, M., Wang, B., Waring, P., Inglese, M., McLoughlin, R.M., Jones, S.A., Topley, N., et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat. Med. 11 (2005), 845–852.
24. Joossens, J.V., Hill, M.J., Elliott, P., Stamler, R., Lesaffre, E., Dyer, A., Nichols, R., Kesteloot, H., European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Dietary salt, nitrate and stomach cancer mortality in 24 countries. Int. J. Epidemiol. 25 (1996), 494–504.
25. Jurk, D., Wilson, C., Passos, J.F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun., 2, 2014, 4172.
26. Karban, A.S., Okazaki, T., Panhuysen, C.I., Gallegos, T., Potter, J.J., Bailey-Wilson, J.E., Silverberg, M.S., Duerr, R.H., Cho, J.H., Gregersen, P.K., et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum. Mol. Genet. 13 (2004), 35–45.
27. Karin, M., NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb. Perspect. Biol., 1, 2009, a000141.
28. Koliaraki, V., Roulis, M., Kollias, G., Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis. J. Clin. Invest. 122 (2012), 4231–4242.
29. Law, C.W., Chen, Y., Shi, W., Smyth, G.K., Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol., 15(2), 2014, R29.
30. Lewander, A., Butchi, A.K., Gao, J., He, L.J., Lindblom, A., Arbman, G., Carstensen, J., Zhang, Z.Y., Sun, X.F., Swedish Low-Risk Colorectal Cancer Study Group. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand. J. Gastroenterol. 42 (2007), 1332–1338.
31. Li, D., Wu, C., Cai, Y., Liu, B., Association of NFKB1 and NFKBIA gene polymorphisms with susceptibility of gastric cancer. Tumour Biol., 39(7), 2017 1010428317717107.
32. Li, P., Gu, J., Yang, X., Cai, H., Tao, J., Yang, X., et al. Functional Promoter −94 ins/del ATTG Polymorphism in NFKB1 Gene Is Associated with Bladder Cancer Risk in a Chinese Population. PLoS ONE, 8, 2013, e71604.
33. Liao, Y., Smyth, G.K., Shi, W., featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30 (2014), 923–930.
34. Lu, R., Gao, X., Chen, Y., Ni, J., Yu, Y., Li, S., Guo, L., Association of an NFKB1 intron SNP (rs4648068) with gastric cancer patients in the Han Chinese population. BMC Gastroenterol., 12, 2012, 87.
35. Maeda, S., Kamata, H., Luo, J.L., Leffert, H., Karin, M., IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121 (2005), 977–990.
36. Meissl, K., Macho-Maschler, S., Müller, M., Strobl, B., The good and the bad faces of STAT1 in solid tumours. Cytokine 89 (2017), 12–20.
37. Naugler, W.E., Karin, M., NF-kappaB and cancer-identifying targets and mechanisms. Curr. Opin. Genet. Dev. 18 (2008), 19–26.
38. Oeckinghaus, A., Ghosh, S., The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol., 1, 2009, a000034.
39. Page, D.B., Postow, M.A., Callahan, M.K., Allison, J.P., Wolchok, J.D., Immune modulation in cancer with antibodies. Annu. Rev. Med. 65 (2014), 185–202.
40. Pardoll, D.M., The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12 (2012), 252–264.
41. Pasparakis, M., Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat. Rev. Immunol. 9 (2009), 778–788.
42. Phipson, B., Lee, S., Majewski, I.J., Alexander, W.S., Smyth, G.K., Robust Hyperparameter Estimation Protects against Hypervariable Genes and Improves Power to Detect Differential Expression. Ann. Appl. Stat. 10 (2016), 946–963.
43. Putoczki, T.L., Thiem, S., Loving, A., Busuttil, R.A., Wilson, N.J., Ziegler, P.K., Nguyen, P.M., Preaudet, A., Farid, R., Edwards, K.M., et al. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell 24 (2013), 257–271.
44. Qing, Y., Li, Q., Ren, T., Xia, W., Peng, Y., Liu, G.L., Luo, H., Yang, Y.X., Dai, X.Y., Zhou, S.F., Wang, D., Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer. Drug Des. Devel. Ther. 9 (2015), 901–909.
45. Ritchie, M.E., Diyagama, D., Neilson, J., van Laar, R., Dobrovic, A., Holloway, A., Smyth, G.K., Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics, 7, 2006, 261.
46. Ritchie, M.E., Phipson, B., Wu, D., Hu, Y., Law, C.W., Shi, W., Smyth, G.K., Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res., 43, 2015, e47.
47. Robinson, M.D., Oshlack, A., A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol., 11, 2010, R25.
48. Robinson, M.D., McCarthy, D.J., Smyth, G.K., edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26 (2010), 139–140.
49. Sasaki, N., Morisaki, T., Hashizume, K., Yao, T., Tsuneyoshi, M., Noshiro, H., Nakamura, K., Yamanaka, T., Uchiyama, A., Tanaka, M., Katano, M., Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin. Cancer Res. 7 (2001), 4136–4142.
50. Satoh, J., Tabunoki, H., A Comprehensive Profile of ChIP-Seq-Based STAT1 Target Genes Suggests the Complexity of STAT1-Mediated Gene Regulatory Mechanisms. Gene Regul. Syst. Bio. 7 (2013), 41–56.
51. Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., Tinevez, J.Y., White, D.J., Hartenstein, V., Eliceiri, K., Tomancak, P., Cardona, A., Fiji: an open-source platform for biological-image analysis. Nat Methods. 9 (2012), 676–682.
52. Sen, R., Baltimore, D., Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47 (1986), 921–928.
53. Sha, W.C., Liou, H.-C., Tuomanen, E.I., Baltimore, D., Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80 (1995), 321–330.
54. Shibata, W., Takaishi, S., Muthupalani, S., Pritchard, D.M., Whary, M.T., Rogers, A.B., Fox, J.G., Betz, K.S., Kaestner, K.H., Karin, M., Wang, T.C., Conditional deletion of IkappaB-kinase-beta accelerates helicobacter-dependent gastric apoptosis, proliferation, and preneoplasia. Gastroenterology 138 (2010), 1022–1034 e1021-1010.
55. Smale, S.T., Dimer-specific regulatory mechanisms within the NF-κB family of transcription factors. Immunol. Rev. 246 (2012), 193–204.
56. Suerbaum, S., Josenhans, C., Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat. Rev. Microbiol. 5 (2007), 441–452.
57. Sugimoto, M., Yamaoka, Y., Furuta, T., Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J. Gastroenterol. 16 (2010), 1188–1200.
58. Sunakawa, Y., Stremitzer, S., Cao, S., Zhang, W., Yang, D., Wakatsuki, T., Ning, Y., Yamauchi, S., Stintzing, S., Sebio, A., El-khoueiry, R., Matsusaka, S., Parekh, A., Barzi, A., Azuma, M., Watanabe, M., Koizumi, W., Lenz, H.-J., Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer. Ann. Oncol. 26 (2015), 332–339.
59. Sutton, P., Kolesnikow, T., Danon, S., Wilson, J., Lee, A., Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon. Infect. Immun. 68 (2000), 4802–4804.
60. Szelag, M., Czerwoniec, A., Wesoly, J., Bluyssen, H.A., Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation. PLoS ONE, 10, 2015, e0116688.
61. Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., Akira, S., Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94 (1997), 3801–3804.
62. Tebbutt, N.C., Giraud, A.S., Inglese, M., Jenkins, B., Waring, P., Clay, F.J., Malki, S., Alderman, B.M., Grail, D., Hollande, F., Heath, J.K., Ernst, M., Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nature Medicine 8 (2002), 1089–1097.
63. Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA Cancer J. Clin. 65 (2015), 87–108.
64. Villarino, A.V., Kanno, Y., O'Shea, J.J., Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat. Immunol. 18 (2017), 374–384.
65. Wang, H., Yang, H., Shivalila, C.S., Dawlaty, M.M., Cheng, A.W., Zhang, F., Jaenisch, R., One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153 (2013), 910–918.
66. Watanabe, N., Iwamura, T., Shinoda, T., Fujita, T., Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation. EMBO J. 16 (1997), 3609–3620.
67. Wilson, C.L., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A.M., Gieling, R.G., Chakraborty, J.B., Fox, C., et al. NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nat. Commun., 6, 2015, 6818.
68. Wroblewski, L.E., Peek, R.M. Jr., Wilson, K.T., Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol. Rev. 23 (2010), 713–739.
69. Wu, C.Y., Wu, M.S., Chiang, E.P., Wu, C.C., Chen, Y.J., Chen, C.J., Chi, N.H., Chen, G.H., Lin, J.T., Elevated plasma osteopontin associated with gastric cancer development, invasion and survival. Gut 56 (2007), 782–789.
70. Wu, D., Lim, E., Vaillant, F., Asselin-Labat, M.L., Visvader, J.E., Smyth, G.K., ROAST: rotation gene set tests for complex microarray experiments. Bioinformatics 26 (2010), 2176–2182.
71. Yang, H.T., Wang, Y., Zhao, X., Demissie, E., Papoutsopoulou, S., Mambole, A., O'Garra, A., Tomczak, M.F., Erdman, S.E., Fox, J.G., et al. NF-κB1 inhibits TLR-induced IFN-β production in macrophages through TPL-2-dependent ERK activation. J. Immunol. 186 (2011), 1989–1996.
72. Zhi, H., Yang, L., Kuo, Y.L., Ho, Y.K., Shih, H.M., Giam, C.Z., NF-κB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ. PLoS Pathog., 7, 2011, e1002025.